Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5 - eviltoast
  • Manmoth@lemmy.ml
    link
    fedilink
    arrow-up
    2
    arrow-down
    2
    ·
    8 months ago

    No idea on the statistics but this does happen. I think the onus is on the government to negotiate for the IP though. Big pharma is going to try to get the best deal they can and most of the time that’s accepting tax dollars and then selling the drug at a more conservative markup to taxpayers. If the government contract was restructured to get the actual IP then they could offer another contract for production and get competing offers.

    • Maggoty@lemmy.world
      link
      fedilink
      arrow-up
      4
      ·
      8 months ago

      Sure. But who is the government going to negotiate for? The people putting money in their campaigns? Or the people who they’ve already trapped into voting for them?

      • Manmoth@lemmy.ml
        link
        fedilink
        arrow-up
        2
        ·
        8 months ago

        Can’t argue with you here. I think this is perhaps the biggest issue we face in the United States. Our government is for sale.